Strata Skin Sciences, Inc.
SSKN
$2.20
-$0.0636-2.81%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -28.86% | 8.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -28.86% | 8.86% | |||
| Cost of Revenue | -17.12% | 9.43% | |||
| Gross Profit | -36.65% | 8.48% | |||
| SG&A Expenses | -6.03% | -11.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.22% | -4.86% | |||
| Operating Income | -450.55% | 77.86% | |||
| Income Before Tax | 47.89% | -119.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 45.92% | -111.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 45.92% | -111.92% | |||
| EBIT | -450.55% | 77.86% | |||
| EBITDA | -192.01% | 308.70% | |||
| EPS Basic | 45.88% | -105.06% | |||
| Normalized Basic EPS | -201.91% | 63.25% | |||
| EPS Diluted | 45.88% | -105.06% | |||
| Normalized Diluted EPS | -201.91% | 63.25% | |||
| Average Basic Shares Outstanding | -0.06% | 3.34% | |||
| Average Diluted Shares Outstanding | -0.06% | 3.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||